Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RAN-DULOXETINE - Health Canada Drug Approval Details

Approvals/Health Canada/RAN-DULOXETINE

Authorized

STANDARD

RAN-DULOXETINE

ranbaxy pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 9619b5753b0c3ce2
Company: ranbaxy pharmaceuticals canada inc.
Type: Standard

Approval Details

Approval Id: 9619b5753b0c3ce2
Drug Approval Canada Name: RAN-DULOXETINE
Product Name: RAN-DULOXETINE
Status: Cancelled Post Market
Status Date: 2025-01-09
Original Market Date: 2016-05-02
Din: 02438259
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX21 DULOXETINE
Atc Name: n 06 ax 21
Aig Number: 0152350001
Company Name: ranbaxy pharmaceuticals canada inc.
Company Address: 126 East Drive, Brampton, Ontario, Canada, L6T 1C1

Active Ingredients

DULOXETINE (DULOXETINE HYDROCHLORIDE)

30 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9619b5753b0c3ce2

Type

Standard

Back to Health Canada Approvals